Clinical manifestations of patients with CASPR2 antibodies

Journal of Neuroimmunology

Volumn 281, Issue , 2015, Pages 17-22

  Sunwoo, Jun Sang ^a   Lee, Soon Tae ^a   Byun, Jung Ick ^a   Moon, Jangsup ^a   Shin, Jung Won ^b   Jeong, Da Eun ^c   Lee, Gun Hee ^d   Jeong, Seong Ho ^e   Shin, Yong Won ^a   Jung, Keun Hwa ^a   Lee, Doo Young ^a   Jeon, Daejong ^a   Jung, Ki Young ^a   Kim, Manho ^a,f   Lee, Sang Kun ^a   Chu, Kon ^a  

^a Seoul National University College of Medicine   (South Korea)

^b CHA University   (South Korea)

^c Chung Ang University College of Medicine   (South Korea)

^d Kyungpook National University School of Medicine   (South Korea)

^e Yonsei University College of Medicine   (South Korea)

^f Seoul National University College of Medicine   (South Korea)

Author keywords

CASPR2; Epilepsy; Immunotherapy; Neuromyotonia

Indexed keywords

ANTICONVULSIVE AGENT; CONTACTIN ASSOCIATED PROTEIN LIKE 2; CONTACTIN ASSOCIATED PROTEIN LIKE 2 ANTIBODY; CORTICOSTEROID; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PROTEIN; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL; AUTOANTIBODY; CNTNAP2 PROTEIN, HUMAN; MEMBRANE PROTEIN; NERVE PROTEIN;

ADULT; AGED; ARTICLE; ASIAN; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BEHAVIOR CHANGE; BRAIN DYSFUNCTION; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONFUSION; DROWSINESS; DRUG MEGADOSE; DYSARTHRIA; EPILEPSY; FEMALE; HUMAN; IMMUNOTHERAPY; INSOMNIA; LABORATORY TEST; LIMB WEAKNESS; MALE; MYOKYMIA; NEUROLOGIC DISEASE; NEUROPATHIC PAIN; OUTCOME ASSESSMENT; PARANEOPLASTIC NEUROPATHY; POLYNEUROPATHY; PRIORITY JOURNAL; SCHOOL CHILD; SEIZURE; TREATMENT RESPONSE; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; BLOOD; FOLLOW UP; HEK293 CELL LINE; IMMUNOLOGY; MIDDLE AGED; PHYSIOLOGY;

ADULT; AGED; AUTOANTIBODIES; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; AUTOIMMUNITY; CHILD; EPILEPSY; FEMALE; FOLLOW-UP STUDIES; HEK293 CELLS; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS;

EID: 84928140991     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2015.03.005     Document Type: Article

References (26)

1. Becker E.B., Zuliani L., Pettingill R., Lang B., Waters P., Dulneva A., Sobott F., Wardle M., Graus F., Bataller L., Robertson N.P., Vincent A. Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia. J. Neurol. Neurosurg. Psychiatry 2012, 83:437-440.
2. Brenner T., Sills G.J., Hart Y., Howell S., Waters P., Brodie M.J., Vincent A., Lang B. Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy. Epilepsia 2013, 54:1028-1035.
3. Irani S.R., Alexander S., Waters P., Kleopa K.A., Pettingill P., Zuliani L., Peles E., Buckley C., Lang B., Vincent A. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain 2010, 133:2734-2748.
4. Irani S.R., Michell A.W., Lang B., Pettingill P., Waters P., Johnson M.R., Schott J.M., Armstrong R.J., A.S.Z., Bleasel A., Somerville E.R., Smith S.M., Vincent A. Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann. Neurol. 2011, 69:892-900.
5. Irani S.R., Pettingill P., Kleopa K.A., Schiza N., Waters P., Mazia C., Zuliani L., Watanabe O., Lang B., Buckley C., Vincent A. Morvan syndrome: clinical and serological observations in 29 cases. Ann. Neurol. 2012, 72:241-255.
6. Irani S.R., Gelfand J.M., Al-Diwani A., Vincent A. Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms. Ann. Neurol. 2014, 76:168-184.
7. Kim T.J., Lee S.T., Shin J.W., Moon J., Lim J.A., Byun J.I., Shin Y.W., Lee K.J., Jung K.H., Kim Y.S., Park K.I., Chu K., Lee S.K. Clinical manifestations and outcomes of the treatment of patients with GABAB encephalitis. J. Neuroimmunol. 2014, 270:45-50.
8. Klein C.J., Lennon V.A., Aston P.A., McKeon A., Pittock S.J. Chronic pain as a manifestation of potassium channel-complex autoimmunity. Neurology 2012, 79:1136-1144.
9. Klein C.J., Lennon V.A., Aston P.A., McKeon A., O'Toole O., Quek A., Pittock S.J. Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping. JAMA Neurol. 2013, 70:229-234.
10. Lai M., Huijbers M.G., Lancaster E., Graus F., Bataller L., Balice-Gordon R., Cowell J.K., Dalmau J. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol. 2010, 9:776-785.
11. Lancaster E., Dalmau J. Neuronal autoantigens-pathogenesis, associated disorders and antibody testing. Nat. Rev. Neurol. 2012, 8:380-390.
12. Lancaster E., Huijbers M.G., Bar V., Boronat A., Wong A., Martinez-Hernandez E., Wilson C., Jacobs D., Lai M., Walker R.W., Graus F., Bataller L., Illa I., Markx S., Strauss K.A., Peles E., Scherer S.S., Dalmau J. Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Ann. Neurol. 2011, 69:303-311.
13. Lee C.H., Lin J.J., Lin K.J., Chang B.L., Hsieh H.Y., Chen W.H., Lin K.L., Fung H.C., Wu T. Caspr2 antibody limbic encephalitis is associated with Hashimoto thyroiditis and thymoma. J. Neurol. Sci. 2014, 341:36-40.
14. Lilleker J.B., Jones M.S., Mohanraj R. VGKC complex antibodies in epilepsy: diagnostic yield and therapeutic implications. Seizure 2013, 22:776-779.
15. Lim J.A., Lee S.T., Jung K.H., Kim S., Shin J.W., Moon J., Byun J.I., Kim T.J., Shin Y.W., Lee K.J., Kim Y.S., Park K.I., Lee S.K., Chu K. Anti-N-methyl-d-aspartate receptor encephalitis in Korea: clinical features, treatment, and outcome. J. Clin. Neurol. 2014, 10:157-161.
16. Linnoila J.J., Rosenfeld M.R., Dalmau J. Neuronal surface antibody-mediated autoimmune encephalitis. Semin. Neurol. 2014, 34:458-466.
17. Malter M.P., Frisch C., Schoene-Bake J.C., Helmstaedter C., Wandinger K.P., Stoecker W., Urbach H., Surges R., Elger C.E., Vincent A.V., Bien C.G. Outcome of limbic encephalitis with VGKC-complex antibodies: relation to antigenic specificity. J. Neurol. 2014, 261:1695-1705.
18. Moon J., Lee S.T., Shin J.W., Byun J.I., Lim J.A., Shin Y.W., Kim T.J., Lee K.J., Park K.I., Jung K.H., Jung K.Y., Lee S.K., Chu K. Non-stiff anti-amphiphysin syndrome: clinical manifestations and outcome after immunotherapy. J. Neuroimmunol. 2014, 274:209-214.
19. Penagarikano O., Abrahams B.S., Herman E.I., Winden K.D., Gdalyahu A., Dong H., Sonnenblick L.I., Gruver R., Almajano J., Bragin A., Golshani P., Trachtenberg J.T., Peles E., Geschwind D.H. Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits. Cell 2011, 147:235-246.
20. Poliak S., Gollan L., Martinez R., Custer A., Einheber S., Salzer J.L., Trimmer J.S., Shrager P., Peles E. Caspr2, a new member of the neurexin superfamily, is localized at the juxtaparanodes of myelinated axons and associates with K+ channels. Neuron 1999, 24:1037-1047.
21. Poliak S., Salomon D., Elhanany H., Sabanay H., Kiernan B., Pevny L., Stewart C.L., Xu X., Chiu S.Y., Shrager P., Furley A.J., Peles E. Juxtaparanodal clustering of Shaker-like K+ channels in myelinated axons depends on Caspr2 and TAG-1. J. Cell Biol. 2003, 162:1149-1160.
22. Quek A.M., Britton J.W., McKeon A., So E., Lennon V.A., Shin C., Klein C., Watson R.E., Kotsenas A.L., Lagerlund T.D., Cascino G.D., Worrell G.A., Wirrell E.C., Nickels K.C., Aksamit A.J., Noe K.H., Pittock S.J. Autoimmune epilepsy: clinical characteristics and response to immunotherapy. Arch. Neurol. 2012, 69:582-593.
23. Shin Y.W., Lee S.T., Shin J.W., Moon J., Lim J.A., Byun J.I., Kim T.J., Lee K.J., Kim Y.S., Park K.I., Jung K.H., Lee S.K., Chu K. VGKC-complex/LGI1-antibody encephalitis: clinical manifestations and response to immunotherapy. J. Neuroimmunol. 2013, 265:75-81.
24. Strauss K.A., Puffenberger E.G., Huentelman M.J., Gottlieb S., Dobrin S.E., Parod J.M., Stephan D.A., Morton D.H. Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2. N. Engl. J. Med. 2006, 354:1370-1377.
25. Toledano M., Britton J.W., McKeon A., Shin C., Lennon V.A., Quek A.M., So E., Worrell G.A., Cascino G.D., Klein C.J., Lagerlund T.D., Wirrell E.C., Nickels K.C., Pittock S.J. Utility of an immunotherapy trial in evaluating patients with presumed autoimmune epilepsy. Neurology 2014, 82:1578-1586.
26. Vincent A., Irani S.R. Caspr2 antibodies in patients with thymomas. J. Thorac. Oncol. 2010, 5:S277-S280.